115 results on '"Term (time)"'
Search Results
2. PSY26 Healthcare Costs, Resource Utilization, and Adverse Events Associated with Long-term Oral Corticosteroid Use in Patients with Systemic Lupus Erythematosus in the United States
3. PMS5 EARLY CARE DECISIONS AND THE RISK OF LONG-TERM OPIOID USE IN PATIENTS WITH LOW BACK PAIN
4. PMH11 LONG-TERM MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER IN THE UNITED STATES: A COST-UTILITY ANALYSIS
5. PGI58 A STUDY OF LONG TERM HOSPITALIZATION COSTS IN PATIENTS WITH ULCERATIVE COLITIS USING GERMAN CLAIMS DATA
6. PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System
7. PRS9 LONG-TERM IMPACT of PRIOR Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilisation (HCRU) and Related Costs: An Observational Study (SHERLOCK)
8. PND27 Modelling LONG-TERM Health Benefits of Siponimod in ACTIVE Secondary Progressive Multiple Sclerosis in Portugal
9. PDG18 LONG-TERM Cost-Effectiveness of the Sofosbuvir-Based Directing-Acting Antivirals in Treating Patients with Chronic Hepatitis C (CHC) in China: From a Healthcare Payer’S Perspective
10. PND15 LONG-TERM COST-EFFECTIVENESS OF LASMIDITAN, UBROGEPANT AND RIMEGEPANT FOR TREATMENT OF ACUTE MIGRAINE
11. PBI33 HOW NOVEL IS ICER METHODS GUIDANCE ON HIGH-IMPACT, SINGLE, AND SHORT-TERM THERAPIES?
12. PRS23 THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN TO THE HEALTHCARE SYSTEM AND FAMILIES OF PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS IN INDONESIA
13. PIN48 THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA
14. PMH16 LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION
15. PCV18 THE LONG-TERM EFFECTS OF MAINTAINING RAASI TREATMENT IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW
16. PUK2 A SYSTEMATIC REVIEW ASSESSING THE LONG-TERM EFFECTS OF MAINTAINING RAASI TREATMENT IN PATIENTS WITH CHRONIC KIDNEY DISEASE
17. PMU30 A SYSTEMATIC REVIEW OF PREVIOUSLY PUSBLISHED OR APPRAISED HEALTH ECONOMIC MODELS ESTIMATING THE SHORT- AND LONG-TERM CONSEQUENCES OF STEROID-SPARING AGENTS
18. Long-Term Effects of Antimicrobial Stewardship Program in A Chinese Tertiary General Hospital: An Interrupted Time-Series Analysis
19. The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia: A Microsimulation Study
20. PCN306 REAL-WORLD STUDY OF HEALTHCARE UTILIZATION AND LONG-TERM PRODUCTIVITY LOSS IN CHRONIC GRAFT VERSUS HOST DISEASE IN SWEDEN
21. PSU22 LONG TERM COST EFFECTIVENESS OF BARIATRIC SURGERY COMPARED TO DIET IN ITALY: PRELIMINARY RESULTS
22. PRS11 HEALTHCARE COSTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND CONCURRENT LONG-TERM USE OF PRESCRIPTION OPIOIDS
23. Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany: A Population-Based Modelling Study
24. Can Bayesian Methodology Predict Long-Term Effectiveness Rather Than Efficacy? An Application with Overall Survival in Two Oncology Indications
25. PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME
26. PND14 - LONG-TERM EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ANTIDEMENTIA THERAPIES IN MEDICARE BENEFICIARIES NEWLY DIAGNOSED WITH ALZHEIMER’S DISEASE
27. PMD68 - A COST-CONSEQUENCE ANALYSIS OF ANACONDA VERSUS PROPOFOL AND MIDAZOLAM IN THE LONG-TERM SEDATION OF CRITICALLY-ILL SURGICAL PATIENTS FROM THE UK NHS PERSPECTIVE
28. Can Qva149 Improve Short Term Outcomes In Patients With Copd Without Increasing The Overall Treatment Costs For The Portuguese Nhs? Optimizing Treatment Outcomes With A Responsible Use Of Limited Resources
29. Quantifying The Cost And Quality Of Life Implications Of Adverse Events Associated With Long-Term Oral Corticosteroid Use
30. Short And Long-Term Economic Impact of Secondary Hyperparathyroidism Treatment in Chronic Kidney Disease in Carlos Andrade Marin Hospital (Ecuador)
31. Improvement of Long Term Risks of Cardiovascular Events Associated with Community Based Disease Management in Chinese Patients of the Xin Jiang Autonomous Region of China
32. Are treatment sequences, adverse events, long-term disease progression adequately considered in cost-effectiveness analyses of rheumatoid arthritis ?: A critical economic litterature review
33. Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine For Tardive Dyskinesia
34. A Comparison of Long-Term Patient Outcomes after Heart Valve Replacement with Biological or Mechanical Valves in Medicare Beneficiaries
35. Evaluating the Long-Term Impact of Improving Care for Patients with Type 2 Diabetes in China
36. Evaluation of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (RTCGM) Versus Self Monitoring Of Blood Glucose (SMBG) Alone In Type 1 Diabetes From The Swedish Societal Perspective
37. Long-term impact of a Pharmacist-Led Diabetes medication management program on Glycemic control
38. Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective
39. Dapagliflozin (Forxiga®) Versus Glipizide As Add-On Therapies In Type 2 Diabetes Mellitus (T2dm); An Update of The Cost-Effectiveness Based On Long-Term Clinical Evidence From Uk Nhs Perspective
40. Long-Term Cost-Effectiveness Of Biphasic Human Insulin 30 In People With Type 2 Diabetes With Inadequate Glycaemic Control On Oral Antidiabetic Drugs In China
41. Evaluation Long-Term Effects Of Treatment And Response On Health Related Quality Of Life Among Patients With Chronic Hepatitis C
42. A Comparison of Long-Term Anticholinergic Burden Derived from Different Risk Scales with Adverse Clinical Outcomes in the Elderly
43. Cost-Effectiveness Analysis of Long-Term Versus Short-Term Dual Antiplatelet Therapy in Patients with Drug-Eluting Stents
44. Choice of First Opioid Prescription and the Transitions from Acute to Long Term Opioid Use – Findings from Big Data
45. The Impact on Long-Term Targeted Therapy with Omalizumab on The Quality of Life According To Registry of Children with Uncontrolled Severe Persistent Asthma (Russian Experience)
46. An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies
47. Modeling the Long Term Economic Benefits of a Patient-Adjusted Mealtime Insulin Titration Algorithm among Patients with Type 2 diabetes in the united States
48. Incidence and Long-Term Cost of Oral Steroid-Related Adverse Events in Chronic Diseases in Poland
49. Assessing the Translatability of the Term 'Frustrated'
50. The cost-of-disease of deep venous thrombosis and its short- and long-term clinical consequences in turkey: An expert panel approach for estimation of costs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.